Literature DB >> 2867413

Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro.

D R Hicks, L S Martin, J P Getchell, J L Heath, D P Francis, J S McDougal, J W Curran, B Voeller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2867413     DOI： 10.1016/s0140-6736(85)92584-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  31 in total

Review 1.  Contraception.

Authors:  A Szarewski; J Guillebaud
Journal:  BMJ       Date:  1991-05-25

2.  A little something for the HIV epidemic?

Authors:  D Kirby
Journal:  BMJ       Date:  1991-04-06

Review 3.  Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.

Authors:  E G Sandström; J C Kaplan
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

4.  Critical design features of phenyl carboxylate-containing polymer microbicides.

Authors:  Robert F Rando; Sakae Obara; Mark C Osterling; Marie Mankowski; Shendra R Miller; Mary L Ferguson; Fred C Krebs; Brian Wigdahl; Mohamed Labib; Hiroyasu Kokubo
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

5.  Solubilization and in vitro spermicidal assessment of nonoxynol-9 and selected fractions using rabbit spermatozoa.

Authors:  B A Walter; A A Hawi; P M Zavos; G A Digenis
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

6.  Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception.

Authors:  Regine Sitruk-Ware; Vivian Brache; Robin Maguire; Horacio Croxatto; Narender Kumar; Sushma Kumar; Juan Carlos Montero; Ana Maria Salvatierra; David Phillips; Anibal Faundes
Journal:  Contraception       Date:  2007-04-18       Impact factor: 3.375

7.  The protective effect of condoms and nonoxynol-9 against HIV infection.

Authors:  K M Wittkowski; E Susser; K Dietz
Journal:  Am J Public Health       Date:  1998-04       Impact factor: 9.308

Review 8.  Non-specific microbicide product development: then and now.

Authors:  Joseph W Romano; Melissa Robbiani; Gustavo F Doncel; Thomas Moench
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

9.  Treatment of the acquired immune deficiency syndrome.

Authors:  S Gupta; M S Gottlieb
Journal:  J Clin Immunol       Date:  1986-05       Impact factor: 8.317

Review 10.  Contraceptive methods and the transmission of HIV: implications for family planning.

Authors:  C C Daly; G E Helling-Giese; J K Mati; D J Hunter
Journal:  Genitourin Med       Date:  1994-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.